Manufacturer Tax Breaks For Patient Assistance Plans Targeted By AIDS Activists
The AIDS Healthcare Foundation has put up billboards, placed sticker advertisements on newspapers, and held protests urging drug makers to lower the cost of HIV/AIDS medicines.
You may also be interested in...
Payments to Medicare providers will be cut if deficit reduction legislation drafted by a joint congressional committee is not enacted by Jan. 15, under the debt ceiling law President Obama signed Aug. 2.
Pink Sheet Podcast: Another Coronavirus Stimulus Bill, Remdesivir’s Brief Orphan Status, Teva Sues Over Copaxone Regulation
Pink Sheet editor and reporters discuss the effects of the latest coronavirus stimulus package on pharma, Gilead’s request for rescission of an orphan designation, and Teva’s suit over Copaxone regulation.
Teva and US FDA disagree over whether Copaxone is a protein. While generics are already on the market, Teva wants to assert process patents against future would-be competitors, which the firm cannot do through the ANDA pathway.